title: The role of peripheral blood stem cells as rescue after myeloablative therapy.
authors.affiliation: Unité de Greffe, Hôpital Haut Levêque, Pessac, France.
authors.forename: J
authors.initials: J
authors.lastname: Reiffers
authors.forename: G
authors.initials: G
authors.lastname: Marit
authors.forename: J M
authors.initials: JM
authors.lastname: Boiron
authors.forename: A
authors.initials: A
authors.lastname: Rice
authors.forename: P
authors.initials: P
authors.lastname: Bernard
authors.forename: G
authors.initials: G
authors.lastname: Vezon
mesh_terms: D000677:Amsacrine / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001803:Blood Transfusion; D003131:Combined Modality Therapy; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D005069:Evaluation Studies as Topic; D006085:Graft Survival; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007937:Leukapheresis; D015470:Leukemia, Myeloid, Acute / Q000097:blood / Q000188:drug therapy / Q000628:therapy*; D008223:Lymphoma / Q000628:therapy; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000628:therapy; D012074:Remission Induction; D014182:Transplantation, Autologous
chemical_list: D000677:Amsacrine; D003561:Cytarabine; D003630:Daunorubicin